Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
THEMISMED | NSE
-4.35
-1.56%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
275.25
279.00
279.50
272.00
Themis Medicare Limited together with its subsidiaries manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas including anti-infective antimalarial anti-tuberculosis cardiology health and nutrition oncology ophthalmology and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Smallcap (300M - 2B USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.0%1 month
46.8%3 months
46.9%6 months
44.5%49.52
-
6.69
0.25
0.17
32.16
6.50
-
596.17M
25.38B
303.08M
0.18
21.77
35.80
27.30
12.14
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
54.75
Range1M
54.75
Range3M
88.95
Rel. volume
0.47
Price X volume
37.48M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.86 | 22.81B | -4.22% | 83.97 | 25.16% |
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 779.25 | 22.51B | -0.87% | 53.49 | 0.60% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2453.25 | 20.90B | 0.82% | 104.10 | 83.75% |
Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 895.3 | 18.77B | 1.57% | 31.83 | 0.81% |
Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 773.5 | 15.52B | 2.17% | 15.67 | 0.18% |
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 131.38 | 13.80B | -2.06% | 17.47 | 10.32% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 399.15 | 11.15B | 4.16% | n/a | 119.57% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 47.86 | 11.03B | -2.09% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 410.1 | 10.85B | 0.05% | 53.99 | 4.77% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1481.35 | 8.45B | -1.90% | 10.74 | 0.87% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 185.77 | 27.39B | 0.19% | 29.68 | 43.67% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 227.83 | 23.44B | -0.81% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.1 | 306.88M | -0.20% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 32.16 | - | Expensive |
Ent. to Revenue | 6.50 | - | Cheaper |
PE Ratio | 49.52 | 47.84 | Par |
Price to Book | 6.69 | 6.55 | Par |
Dividend Yield | 0.18 | - | Poor |
Std. Deviation (3M) | 46.90 | - | Par |
Debt to Equity | 0.25 | 0.34 | Cheaper |
Debt to Assets | 0.17 | 0.17 | Par |
Market Cap | 25.38B | - | Emerging |